F. Schleich (Liège, Belgium), G. Brusselle (Ghent, Belgium)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Neutrophilic inflammation in sputum does not define a clinical distinct asthma phenotype in ATLANTIS
P. Kuks (Groningen, Netherlands), T. Kole (Groningen, Netherlands), M. Kraft (Tucson, Arizona, United States of America), S. Siddiqui (Leicester, United Kingdom), L. Fabbri (Ferrara, Italy), K. Rabe (Grosshansdorf, Germany), G. Nicolini (Parma, Italy), A. Papi (Ferrara, Italy), C. Brightling (Leicester, United Kingdom), D. Singh (Manchester, United Kingdom), N. Zounemat-Kermani (London, United Kingdom), F. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), H. Kerstjens (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands)
|    |
Association between functional small airways disease and 3-year change in emphysema in the SPIROMICS cohort
W. Labaki (Ann Arbor, United States of America), C. Hatt (Minneapolis, United States of America), A. Bell (Ann Arbor, United States of America), C. Galban (Ann Arbor, United States of America), E. Kazerooni (Ann Arbor, United States of America), S. Murray (Ann Arbor, United States of America), J. Curtis (Ann Arbor, United States of America), F. Martinez (New York, United States of America), I. Barjaktarevic (Los Angeles, United States of America), R. Barr (New York, United States of America), R. Bowler (Denver, United States of America), A. Comellas (Iowa City, United States of America), C. Cooper (Los Angeles, United States of America), D. Couper (Chapel Hill, United States of America), G. Criner (Philadelphia, United States of America), M. Dransfield (Birmingham, United States of America), N. Hansel (Baltimore, United States of America), E. Hoffman (Iowa City, United States of America), R. Kanner (Salt Lake City, United States of America), J. Krishnan (Chicago, United States of America), V. Ortega (Winston-Salem, United States of America), R. Paine Iii (Salt Lake City, United States of America), P. Woodruff (San Francisco, United States of America), M. Han (Ann Arbor, United States of America)
| |
Elastic principal graphs for clinical trajectory analysis in COPD: a COPDGene study
A. Bell (Ann Arbor, United States of America), S. Ram (Ann Arbor, United States of America), W. Labaki (Ann Arbor, United States of America), S. Murray (Ann Arbor, United States of America), E. Kazerooni (Ann Arbor, United States of America), S. Galbán (Ann Arbor, United States of America), F. Martinez (New York, United States of America), C. Hatt (Minneapolis, United States of America), E. Mirkes (Leicester, United Kingdom), A. Zinovyev (Paris, France), A. Gorban (Leicester, United Kingdom), M. Han (Ann Arbor, United States of America), C. Galbán (Ann Arbor, United States of America)
| |
Identification of distinct trajectories of FEV1 progression in the ECLIPSE cohort
S. Rønnow (Herlev, Denmark), J. P.M. Blair (Herlev, Denmark), J. M.B. Sand (Herlev, Denmark), B. E. Miller (Washington, United States of America), R. Tal-Singer (Washington, United States of America), J. Vestbo (Manchester, United Kingdom), M. A. Karsdal (Herlev, Denmark), D. J. Leeming (Herlev, Denmark)
| |
Salivary microbiota composition is associated with severe exacerbations
S. Melo-Dias (Aveiro, Portugal), C. Valente (Aveiro, Portugal), L. Andrade (Aveiro, Portugal), A. Marques (Aveiro, Portugal), A. Sousa (Aveiro, Portugal)
| |
Exhaled breath analyses in bronchial thermoplasty for severe asthma
P. Wijsman (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), A. Goorsenberg (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), J. D'Hooghe (Amsterdam, Netherlands), E. Weersink (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), J. Annema (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands)
| |
Quantification of inflammatory cytokines in exhaled breath particles following segmental and inhalation endotoxin challenge of healthy volunteers
O. Holz (Hannover, Germany), S. Carstensen (Hannover, Germany), M. Müller (Hannover, Germany), A. Olin (Gothenburg, Sweden), J. Hohlfeld (Hannover, Germany)
| |
Treatable traits in the NOVELTY study: prevalence, patterns and relationship with physician-assessed severity
A. Agusti (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), R. Hughes (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), A. Papi (Ferrara, Italy), I. Pavord (Oxford, United Kingdom), R. Faner (Barcelona, Spain)
| |
The carnitine pathway is dysregulated in asthma in an oral corticosteroid-independent mechanism
S. Reinke (Joondalup, Australia), S. Naz (Stockholm, Sweden), N. Kermani (London, United Kingdom), R. Chaleckis (Maebashi, Japan), J. Kolmert (Stockholm, Sweden), M. Ström (Stockholm, Sweden), Å. Wheelock (Stockholm, Sweden), R. Djukanovic (Southampton, United Kingdom), F. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), S. Dahlen (Stockholm, Sweden), C. Wheelock (Stockholm, Sweden), .. Ubiopred Study Group (Stockholm, Sweden)
| |
Late Breaking Abstract - Performance of artificial intelligence in determining the intensity of abnormal breath sounds in asthma patients.
T. Grzywalski (Poznan, Poland), A. Maciaszek (Poznan, Poland), K. Szarzynski (Poznan, Poland), H. Hafke-Dys (Poznan, Poland), J. Kocinski (Poznan, Poland), B. Kuzniar-Kaminska (Poznan, Poland)
| |
Discussion
| |